Novavax director acquires 9,520 shares via RSUs
Novavax Inc. director Charles W. Newton acquired common shares through an RSU-related transaction.
Rhea-AI Filing Summary
Novavax Inc. director Charles W. Newton acquired common shares through an RSU-related transaction. On April 25, 2026, he exercised derivative rights linked to Restricted Stock Units (RSUs), resulting in ownership of 9,520 shares of Novavax common stock held directly after the transaction.
Each RSU represents a contingent right to receive one share of Novavax common stock. According to the grant terms, the RSUs will vest in three equal annual installments, with one-third of the RSUs scheduled to vest on each of the first three anniversaries of April 25, 2025, subject to his continued service on the company’s Board of Directors.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Restricted Stock Units | 9,520 | $0.00 | $0.00 |
| Exercise | Common Stock | 9,520 | $0.00 | $0.00 |
Footnotes (2)
- F1. Each restricted stock unit ("RSU") represents a contingent right to receive one share of Company common stock.
- F2. The RSUs subject to this grant under the Plan will vest with respect to one-third (1/3) of the RSUs on each of the first three (3) anniversaries of April 25, 2025, in each case subject to continued service on the Company's Board of Directors through such vesting date.
Key Figures
Key Terms
Restricted Stock Units financial
RSU financial
contingent right financial
vest financial
continued service financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did Novavax (NVAX) director Charles W. Newton report?
What are the terms of Charles W. Newton’s Novavax (NVAX) RSU grant?
Did the Novavax (NVAX) Form 4 report a stock sale by Charles W. Newton?
How many Restricted Stock Units were involved in Charles W. Newton’s Novavax (NVAX) transaction?
AI-generated analysis. How Rhea-AI works. Not financial advice.